Potential clinical application of dapagliflozin in patients with chronic heart failure in real life clinical practice: Results from TREAT HF Study

Basit Öğe Kaydı
dc.authoridKaya, Hakki/0000-0001-5230-635X
dc.contributor.authorCavusoglu, Y. Yuksel
dc.contributor.authorKaya, H.
dc.contributor.authorYilmaz, M. B.
dc.date.accessioned2025-01-27T21:24:06Z
dc.date.available2025-01-27T21:24:06Z
dc.date.issued2020
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[Anstract Not Available]
dc.identifier.endpage276
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.startpage275
dc.identifier.urihttps://hdl.handle.net/20.500.12428/29432
dc.identifier.volume22
dc.identifier.wosWOS:000787777901239
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofEuropean Journal of Heart Failure
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.titlePotential clinical application of dapagliflozin in patients with chronic heart failure in real life clinical practice: Results from TREAT HF Study
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu